LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (Amex: BPA) announced today that it has received notification from The NASDAQ Stock Market LLC® that BioSante’s common stock is approved for listing on The NASDAQ Global Market. BioSante’s board of directors approved the decision to switch the listing of BioSante’s common stock from The American Stock Exchange to The NASDAQ Stock Global Market LLC®. BioSante currently is going through all the required regulatory processes associated with the switch and expects its common stock to begin trading on NASDAQ under the symbol BPAX in early to mid-November 2007. BioSante’s common stock will continue to trade on the American Stock Exchange under its current symbol BPA until such date.
